Wnt1-Cre-mediated deletion of AP-2α causes multiple neural crest-related defects

Developmental Biology

Volumn 267, Issue 1, 2004, Pages 135-152

  Brewer, Stephanie ^a   Feng, Weiguo ^b   Huang, Jian ^a,b   Sullivan, Shelley ^b   Williams, Trevor ^a,b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

AP 2 ; Neural crest cell; tcfap2a

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; EMBRYO; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; MIDDLE EAR; MIDDLE EAR MALFORMATION; MOUSE; MOUSE MUTANT; NERVOUS SYSTEM DEVELOPMENT; NEURAL CREST; NEURAL CREST CELL; NEURAL TUBE DEFECT; NONHUMAN; PERINATAL DEATH; PHENOTYPE; PIGMENT DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

VERTEBRATA;

EID: 1242295315     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2003.10.039     Document Type: Article

References (86)

1. Ahituv, N., Erven, A., Fuchs, H., Ashery-Padan, R., Williams, T., de Angelis, M.H., Avraham, K.B., and Steel, K.P., submitted for publication. A gain of function mutation in AP-2α leads to middle ear and ocular defects.
2. Auman H.J., Nottoli T., Lakiza O., Winger Q., Donaldson S., Williams T. Transcription factor AP-2γ is essential in the extra-embryonic lineages for early postimplantation development. Development. 129:2002;2733-2747.
3. Bally-Cuif L., Cholley B., Wassef M. Involvement of Wnt-1 in the formation of the mes/metencephalic boundary. Mech. Dev. 53:1995;23-34.
4. Bar-Eli M. Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res. 14:2001;78-85.
5. Bennett D.C., Lamoreux M.L. The color loci of mice - A genetic century. Pigment Cell Res. 16:2003;333-344.
6. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., Sommer L., Boussadia O., Kemler R. Inactivation of the β-catenin gene by Wnt1-Cre mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 128:2001;1253-1264.
7. Brewer, S., Williams, T., submitted. Loss of AP-2α impacts multiple aspects of ventral body wall development and closure. Dev. Biol., in press.
8. Brewer S., Jiang X., Donaldson S., Williams T., Sucov H.M. Requirement for AP-2α in cardiac outflow tract morphogenesis. Mech. Dev. 110:2002;139-149.
9. Byrne C., Tainsky M., Fuchs E. Programming gene expression in developing epidermis. Development. 120:1994;2369-2383.
10. Chai Y., Jiang X., Ito Y., Bringas P. Jr., Han J., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Dev., -Suppl. 127:2000;1671-1679.
11. Cheng C., Ying K., Xu M., Zhao W., Zhou Z., Huang Y., Wang W., Xu J., Zeng L., Xie Y., Mao Y. Cloning and characterization of a novel human transcription factor AP-2β like gene (TFAP2BL1). Int. J. Biochem. Cell Biol. 34:2002;78-86.
12. Copp A.J., Greene N.D., Murdoch J.N. The genetic basis of mammalian neurulation. Nat. Rev., Genet. 4:2003;784-793.
13. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8:1998;1323-1326.
14. David N.B., Saint-Etienne L., Tsang M., Schilling T.F., Rosa F.M. Requirement for endoderm and FGF3 in ventral head skeleton formation. Development. 129:2002;4457-4468.
15. Davies A.F., Stephens R.J., Olavesen M.G., Heather L., Dixon M.J., Magee A., Flinter F., Ragoussis J. Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum. Mol. Genet. 4:1995;121-128.
16. Davies A.F., Mirza G., Sekhon G., Turnpenny P., Leroy F., Speleman F., Law C., van Regemorter N., Vamos E., Flinter F., Ragoussis J. Delineation of two distinct 6p deletion syndromes. Hum. Genet. 104:1999;64-72.
17. Feng W., Williams T. Cloning and characterization of the mouse AP-2ε gene: a novel family member expressed in the developing olfactory bulb. Mol. Cell. Neurosci. 24:2003;460-475.
18. Francis-West P.H., Robson L., Evans D.J. Craniofacial development: the tissue and molecular interactions that control development of the head. Adv. Anat. Embryol. Cell Biol. 169(III-IV):2003;1-138.
19. Furthauer M., Thisse C., Thisse B. A role for FGF-8 in the dorsoventral patterning of the zebrafish gastrula. Development. 124:1997;4253-4264.
20. Garcia M.A., Campillos M., Ogueta S., Valdivieso F., Vazquez J. Identification of amino acid residues of transcription factor AP-2 involved in DNA binding. J. Mol. Biol. 301:2000;807-816.
21. Gee J.M., Robertson J.F., Ellis I.O., Nicholson R.I., Hurst H.C. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J. Pathol. 189:1999;514-520.
22. Gendron-Maguire M., Mallo M., Zhang M., Gridley T. Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest. Cell. 75:1993;1317-1331.
23. Golden J.A., Bracilovic A., McFadden K.A., Beesley J.S., Rubenstein J.L., Grinspan J.B. Ectopic bone morphogenetic proteins 5 and 4 in the chicken forebrain lead to cyclopia and holoprosencephaly. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2439-2444.
24. Hall B.K. The Neural Crest in Development and Evolution. 1999;Springer-Verlag, New York.
25. Hilger-Eversheim K., Moser M., Schorle H., Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene. 260:2000;1-12.
26. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the Mouse Embryo. 1994;CSHL Press, Cold Spring Harbor.
27. Holzschuh J., Barrallo-Gimeno A., Ettl A.K., Durr K., Knapik E.W., Driever W. Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype. Development. 130:2003;5741-5754.
28. Hu D., Marcucio R.S., Helms J.A. A zone of frontonasal ectoderm regulates patterning and growth in the face. Development. 130:2003;1749-1758.
29. Jiang X., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cardiac neural crest. Dev., Suppl. 127:2000;1607-1616.
30. Jiang X., Iseki S., Maxson R.E., Sucov H.M., Morriss-Kay G.M. Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 241:2002;106-116.
31. Juriloff D.M., Harris M.J. Mouse models for neural tube closure defects. Hum. Mol. Genet. 9:2000;993-1000.
32. Kaufman M.H., Bard J.B.L. The Anatomical Basis of Mouse Development. 1999;Academic Press, San Diego, CA.
33. Kennedy B., Enns R., Nelson D., Williams T., Bao X., Ziegler M.G. Reduction of adrenal and kidney epinephrine and phenylethanolamine N-methyltransferase in AP-2 knockout mouse fetuses. Ann. N. Y. Acad. Sci. 971:2002;92-94.
34. Knecht A.K., Bronner-Fraser M. Induction of the neural crest: a multigene process. Nat. Rev., Genet. 3:2002;453-461.
35. Knight K.D., Naair S., Nelson S.S., Afshar A., Javidan Y., Geisler R., Rauch G.-J., Schilling T.F. Lockjaw encodes a zebrafish tfap2a required for early neural crest development. Development. 130:2003;5755-5768.
36. LaBonne C., Bronner-Fraser M. Molecular mechanisms of neural crest formation. Annu. Rev. Cell Dev. Biol. 15:1999;81-112.
37. Law C.J., Fisher A.M., Temple I.K. Distal 6p deletion syndrome: a report of a case with anterior chamber eye anomaly and review of published reports. J. Med. Genet. 35:1998;685-689.
38. Le Douarin N., Kalcheim C. The Neural Crest. 1999;Cambridge Univ. Press, Cambridge.
39. Luo T., Matsuo-Takasaki M., Thomas M.L., Weeks D.L., Sargent T.D. Transcription factor AP-2 is an essential and direct regulator of epidermal development in Xenopus. Dev. Biol. 245:2002;136-144.
40. Luo T., Lee Y.H., Saint-Jeannet J.P., Sargent T.D. Induction of neural crest in Xenopus by transcription factor AP-2α Proc. Natl. Acad. Sci. U. S. A. 100:2003;532-537.
41. Maconochie M., Krishnamurthy R., Nonchev S., Meier P., Manzanares M., Mitchell P.J., Krumlauf R. Regulation of Hoxa2 in cranial neural crest cells involves members of the AP-2 family. Development. 126:1999;1483-1494.
42. Mallo M. Formation of the middle ear: recent progress on the developmental and molecular mechanisms. Dev. Biol. 231:2001;410-419.
43. Mao J.J. Mechanobiology of craniofacial sutures. J. Dent. Res. 81:2002;810-816.
44. Mark M., Lufkin T., Vonesch J.L., Ruberte E., Olivo J.C., Dollé P., Gorry P., Lumsden A., Chambon P. Two rhombomeres are altered in Hoxa-1 mutant mice. Development. 119:1993;319-338.
45. Martin J.F., Bradley A., Olson E.N. The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev. 9:1995;1237-1249.
46. McPherson L.A., Weigel R.J. AP-2α and AP-2γ: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic Acids Res. 27:1999;4040-4049.
47. Meulemans D., Bronner-Fraser M. Amphioxus and lamprey AP-2 genes: implications for neural crest evolution and migration patterns. Development. 129:2002;4953-4962.
48. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18:1998;136-141.
49. Mitchell P.J., Timmons P.M., Hebert J.M., Rigby P.W.J., Tjian R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5:1991;105-119.
50. Mohibullah N., Donner A., Ippolito J.A., Williams T. SELEX and missing phosphate contact analyses reveal flexibility within the AP-2α protein: DNA binding complex. Nucleic Acids Res. 27:1999;2760-2769.
51. Moser M., Pscherer A., Roth C., Becker J., Mucher G., Zerres K., Dixkens C., Weis J., Guay-Woodford L., Buettner R., Fassler R. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β Genes Dev. 11:1997;1938-1948.
52. Murray J.C. Gene/environment causes of cleft lip and/or palate. Clin. Genet. 61:2002;248-256.
53. Nelson D.K., Williams T. Frontonasal process-specific disruption of AP-2α results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects. Dev. Biol. 267:2003;72-92.
54. Neuhauss S.C., Solnica-Krezel L., Schier A.F., Zwartkruis F., Stemple D.L., Malicki J., Abdelilah S., Stainier D.Y., Driever W. Mutations affecting craniofacial development in zebrafish. Development. 123:1996;357-367.
55. Nottoli T., Hagopian-Donaldson S., Zhang J., Perkins A., Williams T. AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13714-13719.
56. Nyormoi O., Bar-Eli M. Transcriptional regulation of metastasis-related genes in human melanoma. Clin. Exp. Metastasis. 20:2003;251-263.
57. Ohnemus S., Bobola N., Kanzler B., Mallo M. Different levels of Hoxa2 are required for particular developmental processes. Mech. Dev. 108:2001;135-147.
58. Opperman L.A. Cranial sutures as intramembranous bone growth sites. Dev. Dyn. 219:2000;472-485.
59. Qiu M., Bulfone A., Martinez S., Meneses J.J., Shimamura K., Pedersen R.A., Rubenstein J.L. Null mutation of Dlx-2 results in abnormal morphogenesis of proximal first and second branchial arch derivatives and abnormal differentiation in the forebrain. Genes Dev. 9:1995;2523-2538.
60. Qiu M., Bulfone A., Ghattas I., Meneses J.J., Christensen L., Sharpe P.T., Presley R., Pedersen R.A., Rubenstein J.L. Role of the Dlx homeobox genes in proximodistal patterning of the branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogenesis of proximal skeletal and soft tissue structures derived from the first and second arches. Dev. Biol. 185:1997;165-184.
61. Rijli F.M., Mark M., Lakkaraju S., Dierich A., Dollé P., Chambon P. A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene. Cell. 75:1993;1333-1349.
62. Rossant J., Tam P.P.L. Mouse Development: Patterning, Morphogenesis, and Organogenesis. 2002;Academic, San Diego, CA.
63. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual. 2001;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
64. Schilling T.F. Genetic analysis of craniofacial development in the vertebrate embryo. Bioessays. 19:1997;459-468.
65. Schilling T.F., Piotrowski T., Grandel H., Brand M., Heisenberg C.P., Jiang Y.J., Beuchle D., Hammerschmidt M., Kane D.A., Mullins M.C., van Eeden F.J., Kelsh R.N., Furutani-Seiki M., Granato M., Haffter P., Odenthal J., Warga R.M., Trowe T., Nusslein-Volhard C. Jaw and branchial arch mutants in zebrafish I: branchial arches. Development. 123:1996;329-344.
66. Schorle H., Meier P., Buchert M., Jaenisch R., Mitchell P.J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature. 381:1996;235-238.
67. Shen H., Wilkie T., Ashique A.M., Narvey M., Zerucha T., Savino E., Williams T., Richman J.M. Chicken transcription factor AP-2: cloning, expression and its role in outgrowth of facial prominences and limb buds. Dev. Biol. 188:1997;248-266.
68. Spritz R.A. The genetics and epigenetics of orofacial clefts. Curr. Opin. Pediatr. 13:2001;556-560.
69. Spritz R.A., Chiang P.W., Oiso N., Alkhateeb A. Human and mouse disorders of pigmentation. Curr. Opin. Genet. Dev. 13:2003;284-289.
70. Steel K.P., Barkway C. Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development. 107:1989;453-463.
71. Topping A., Harris P., Moss A.L. The 6p deletion syndrome: a new orofacial clefting syndrome and its implications for antenatal screening. Br. J. Plast. Surg. 55:2002;68-72.
72. Trainor P., Krumlauf R. Plasticity in mouse neural crest cells reveals a new patterning role for cranial mesoderm. Nat. Cell Biol. 2:2000;96-102.
73. Trainor P.A., Krumlauf R. Hox genes, neural crest cells and branchial arch patterning. Curr. Opin. Cell Biol. 13:2001;698-705.
74. Turner B.C., Zhang J., Gumbs A.A., Maher M.G., Kaplan L., Carter D., Glazer P.M., Hurst H.C., Haffty B.G., Williams T. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res. 58:1998;5466-5472.
75. Wankhade S., Yu Y., Weinberg J., Tainsky M.A., Kannan P. Characterization of the activation domains of AP-2 family transcription factors. J. Biol. Chem. 275:2000;29701-29708.
76. Warren G., Gordon M., Siracusa L.D., Buchberg A.M., Williams T. Physical and genetic localization of the gene encoding the AP-2 transcription factor to mouse chromosome 13. Genomics. 31:1996;234-237.
77. West-Mays J.A., Zhang J., Nottoli T., Hagopian-Donaldson S., Libby D., Strissel K.J., Williams T. AP-2α transcription factor is required for early morphogenesis of the lens vesicle. Dev. Biol. 206:1999;46-62.
78. Widlund H.R., Fisher D.E. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene. 22:2003;3035-3041.
79. Wilkie A.O., Morriss-Kay G.M. Genetics of craniofacial development and malformation. Nat. Rev., Genet. 2:2001;458-468.
80. Williams T., Tjian R. Analysis of the DNA binding and activation properties of the human transcription factor AP-2. Genes Dev. 5:1991;670-682.
81. Williams T., Tjian R. A novel dimerization motif in transcription factor AP-2 can be utilized by other DNA binding proteins. Science. 251:1991;1067-1071.
82. Yamauchi Y., Abe K., Mantani A., Hitoshi Y., Suzuki M., Osuzu F., Kuratani S., Yamamura K. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev. Biol. 212:1999;191-203.
83. Zhang J., Williams T. Identification and regulation of tissue-specific cis-acting elements associated with the human AP-2α gene. Dev. Dyn. 228:2003;194-207.
84. Zhang J., Hagopian-Donaldson S., Serbedzija G., Elsemore J., Plehn-Dujowich D., McMahon A.P., Flavell R.A., Williams T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature. 381:1996;238-241.
85. Zhang J., Brewer S., Huang J., Williams T. Overexpression of transcription factor AP-2α suppresses mammary gland growth and morphogenesis. Dev. Biol. 256:2003;127-145.
86. Zhao F., Satoda M., Licht J.D., Hayashizaki Y., Gelb B.D. Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2δ, with unique DNA binding and transactivation properties. J. Biol. Chem. 276:2001;40755-40760.